Clinical Trial Update: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Clofarabine plus Melphalan as a conditioning regimen before donor stem cell transplantation for patients with myelodysplastic syndromes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• Therapy-related Myelodysplastic Syndrome

Drugs mentioned

• Clolar (Clofarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-04